These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 35274573)
1. [Therapeutic drug monitoring to optimize psychopharmacotherapy in children and adolescents - Update and guidelines for practice]. Egberts K; Fekete S; Häge A; Hiemke C; Scherf-Clavel M; Taurines R; Unterecker S; Gerlach M; Romanos M Z Kinder Jugendpsychiatr Psychother; 2021 Mar; 50(2):133-152. PubMed ID: 35274573 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacovigilance in child and adolescent psychiatry]. Egberts K; Karwautz A; Plener PL; Mehler-Wex C; Kölch M; Dang SY; Taurines R; Romanos M; Gerlach M Z Kinder Jugendpsychiatr Psychother; 2015 Jan; 43(1):21-8. PubMed ID: 25536893 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring in child and adolescent psychiatry. Egberts KM; Mehler-Wex C; Gerlach M Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring as a measure of proactive pharmacovigilance in child and adolescent psychiatry. Gerlach M; Egberts K; Dang SY; Plener P; Taurines R; Mehler-Wex C; Romanos M Expert Opin Drug Saf; 2016 Nov; 15(11):1477-1482. PubMed ID: 27551945 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]. Gerlach M; Rothenhöfer S; Mehler-Wex C; Fegert JM; Schulz E; Wewetzer C; Warnke A Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):5-13. PubMed ID: 16485609 [TBL] [Abstract][Full Text] [Related]
6. Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy. Mehler-Wex C; Kölch M; Kirchheiner J; Antony G; Fegert JM; Gerlach M Child Adolesc Psychiatry Ment Health; 2009 Apr; 3(1):14. PubMed ID: 19358696 [TBL] [Abstract][Full Text] [Related]
7. [Psychopharmacotherapy during pregnancy and breastfeeding-Part I: focus on pregnancy : Support options by using therapeutic drug monitoring]. Paulzen M; Schoretsanitis G Nervenarzt; 2023 Sep; 94(9):786-798. PubMed ID: 37460797 [TBL] [Abstract][Full Text] [Related]
8. BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents. Sharma AN; Arango C; Coghill D; Gringras P; Nutt DJ; Pratt P; Young AH; Hollis C J Psychopharmacol; 2016 May; 30(5):416-21. PubMed ID: 27098018 [TBL] [Abstract][Full Text] [Related]
11. Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic review. Kloosterboer SM; Vierhout D; Stojanova J; Egberts KM; Gerlach M; Dieleman GC; Hillegers MHJ; Passe KM; Gelder TV; Dierckx B; Koch BCP Expert Opin Drug Saf; 2020 Jul; 19(7):873-890. PubMed ID: 32421365 [TBL] [Abstract][Full Text] [Related]
12. The need to improve current psychopharmacotherapy before developing new drugs. Ceskova E Expert Opin Pharmacother; 2014 Oct; 15(14):1969-73. PubMed ID: 25146687 [TBL] [Abstract][Full Text] [Related]
13. AHA Scientific Statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Gutgesell H; Atkins D; Barst R; Buck M; Franklin W; Humes R; Ringel R; Shaddy R; Taubert KA J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):1047-50. PubMed ID: 10434498 [No Abstract] [Full Text] [Related]
14. Psychotropic medication use in children and adolescents in an inpatient setting. Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844 [TBL] [Abstract][Full Text] [Related]
15. [Safety of psychopharmacotherapy: a clinical and pharmacological approach]. Kirilochev OO; Umerova AR Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):127-133. PubMed ID: 31793554 [TBL] [Abstract][Full Text] [Related]
16. [Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives]. Dumortier G; Welniarz B; Sauvebois C; Medjdoub H; Friche H; Siad N; Degrassat K Encephale; 2005; 31(4 Pt 1):477-89. PubMed ID: 16389715 [TBL] [Abstract][Full Text] [Related]
17. [Prescriptions of psychotropic drugs to children and adolescents in Germany]. Franke C; Fegert JM; Krüger U; Kölch M Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):259-74. PubMed ID: 27058834 [TBL] [Abstract][Full Text] [Related]
18. Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs. Jureidini J; Tonkin A; Jureidini E Paediatr Drugs; 2013 Oct; 15(5):377-91. PubMed ID: 23757196 [TBL] [Abstract][Full Text] [Related]
19. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G; Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191 [TBL] [Abstract][Full Text] [Related]
20. [Psychopharmacotherapy during pregnancy and breastfeeding-Part II: focus on breastfeeding : Support options by using therapeutic drug monitoring]. Paulzen M; Schoretsanitis G Nervenarzt; 2023 Sep; 94(9):801-810. PubMed ID: 37449995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]